Baldwin Corporation is a public corporation listed on New York Stock Exchange (NYSE) market. The company researches, develops, manufactures, and sells various products in the health care industry worldwide. Baldwin Inc. operates in three main segments: consumer, pharmaceutical, and medical devices segments. The primary corporate objective of the company is to maximize the value of the owners’ equity by increasing the price of its shares in the stock market. Unfortunately, the company’s stock price has been declining over the past year because of declining sales, cash flow uncertainties, and weak financial ratios. The board of directors have hired a new CFO, Jeff Warren to turnaround the fortunes of the company. Jeff earned his PhD in Finance from UC in 2018. After his MBA he worked for five years as sales and marketing consultant for a pharmaceutical company. As a result, Jeff does not have much work experience in corporate finance, although in his graduate finance courses, he learnt about time value of money and its applications in financial and investment decisions.
Despite his lack of experience in corporate finance, Jeff wants to create value for the company through efficient management of working capital, and prudent capital budgeting activities by expanding the company’s products into new markets. He is considering a capital investment either in the State of Ohio or North Dakota because of growing market demand for the company’s products in both States and the recent changes to the States’ tax legislations that give tax incentives to new companies. The company has announced plans to invest about $2.2 million in its medical devices and pharmaceutical segments. Jeff believes that decisions such as these, with price tags in the millions, are obviously major undertakings, and the risks and rewards must be carefully weighed. Jeff knows that good financial decisions increase the value of a company’s stock, and bad financial decisions decrease the value of the stock. Jeff is working hard to make Baldwin Inc. one of the leading firms in the health care industry.
Jeff has been reading articles in financial journals on capital budgeting decisions and risk analysis. He has written down the following ideas on project evaluation techniques from book chapters and peer-reviewed articles:
2.Payback period is the number of years required for a company to recover the initial investment cost.
Decision Criteria of NPV
If NPV > 0, accept the project
If NPV < 0, reject the project
The decision rule for mutually exclusive project is to select the project with the highest NPV.
Decision Rule:
Accept the project if IRR > cost of capital
Reject the project if IRR < cost of capital
Exhibit 1: The expected cash flows in US$ from the project in Ohio and North Dakota.
Year
Cash flow (Ohio)
Cash flow (ND)
0
(2,200,000)
(2,400,000)
1*
500,000
350,000
2
245,000
185,000
3
287,000
205,000
4
300,000
290,000
5
388,000
380,000
6
480,000
590,000
7
530,000
400,000
8
585,000
583,000
9
590,000
580,000
10
692,000
720,000
*note: The year 1 cash flow includes government stimulus payment of $100,000 to support business projects.
The company’s policy is to select projects using NPV technique.
a. Calculate the payback period for the two projects.
b. Calculate the IRR of both projects.
c. Use the NPV technique to recommend which investment project it should accept, assuming the cost of capital of financing the Ohio project is 12% and 10% for the North Dakota project?
a. Explain to Baldwin Inc. how the two risk analysis models can be used to analyze risk of the project.